4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-19-009067
President and General Counsel sold 7,519 shares at $23.99 ($180,381)
- President and General Counsel acquired 7,519 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2019-02-14 | Option exercise | −7,519 | $15.23 | $114,514 | 175,837 | D |
| Shandell Jason B. President and General Counsel | 2019-02-14 | Sale | −7,519 | $23.99 | $180,381 | 168,318 | D |
| Derivatives | |||||||
| Shandell Jason B. President and General Counsel | 2019-02-14 | Option exercise · Employee Stock Option (right to buy) | −7,519 | 0 | D | ||
| Open-market sales · 7,519 sh · avg $23.99 · $180,381 | |||||||
Loading xslF345X03/a4.xml…